Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HER2 Negative Breast Cancer × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 130 Breast Neoplasms 71 Colorectal Neoplasms 58 Neoplasms 47 Lung Neoplasms 46 Pancreatic Neoplasms 41 Stomach Neoplasms 40 Neoplasm Metastasis 40 Rectal Neoplasms 39 Ovarian Neoplasms 38 Esophageal Squamous Cell Carcinoma 32 Squamous Cell Carcinoma of Head and Neck 28 Esophageal Neoplasms 27 Head and Neck Neoplasms 26 Leukemia, Myeloid, Acute 23 Recurrence 20 Small Cell Lung Carcinoma 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Nasopharyngeal Carcinoma 19 Triple Negative Breast Neoplasms 18 Glioblastoma 17 Fallopian Tube Neoplasms 17 Prostatic Neoplasms 16 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Uterine Cervical Neoplasms 15 Colonic Neoplasms 15 Carcinoma, Squamous Cell 14 Sarcoma 13 Melanoma 13

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡